06/22/2017 - 9:32am

According to the CDC, American adults are behind on routine annual vaccinations.

06/20/2017 - 1:48pm

The company said that it’s expecting a launch in the second-half of 2017, and that it has already submitted an application to the FDA for a junior version of Symjepi.

06/20/2017 - 1:01pm

The drug is indicated as an adjunctive therapy to relieve discomfort associated with acute, painful musculoskeletal conditions.

06/20/2017 - 11:40am

This launch marks the seventh product ANI has re-commercialized after acquiring a portfolio of discontinued generic abbreviated new drug applications. 

06/20/2017 - 9:30am

The company said that this marks its fourth first-to-market generic launch since June 2016.

06/20/2017 - 9:18am

The drug had U.S. sales of $15 million for the 12 months ended April 2017, Perrigo said.

06/19/2017 - 1:43pm
The drug is indicated for the control of serum phosphorus in patients with chronic kidney disease.
06/16/2017 - 9:46am
The company is distributing the generic in 30-, 90- and 500-count bottle sizes, and has begun shipping the product from its Kentucky distribution center.
06/15/2017 - 2:59pm

CVS Health’s April survey found that 88% of respondents are somewhat or very concerned about the high cost of prescription drugs.